Alain Merieux was born in Lyon, France, France. Alain Merieux is chairman of Institut Merieux, a medicine and public health conglomerate specializing in diagnostics, immunotherapy and nutrition. Alain's grandfather, Marcel Merieux, a laboratory aide to Louis Pasteur, founded the institute in 1897. Alain founded BioMerieux, one of the firm's publicly traded arms, which specializes in diagnostic tests for infectious diseases such as HIV and tuberculosis. BioMerieux currently operates in 150 countries and has more than 9,000 employees. The firm's other publicly-traded subsidiary, Transgene, develops vaccines to combat infectious diseases. Alain's oldest son Rodolphe was killed in 1996 at age 27 when TWA Flight 800 crashed in Long Island. His second son, Christophe, who was expected to take over the family business, died of cardiac failure in 2006 at age 39. His third son, Alexandre, who shares the fortune, was named CEO of BioMerieux in 2014. In 2015 Alain was made Grand Officer in the French Legion of Honour, one of the most prestigious civilian honors in France, for his outstanding service in the global health industry.
Alain Merieux is a member of Health care
💰Alain Merieux Net worth: $3.2 Billion (Updated at 22 June 2018)
2009
$2.4 Billion
2010
$4 Billion
2011
$4.3 Billion
2012
$3.7 Billion
2013
$3.1 Billion
2014
$3.8 Billion
2015
$3.5 Billion
2016
$3.3 Billion
2017
$4 Billion
2018
$3.15 Billion
Some Alain Merieux images
Biography/Timeline
1907
Alain Mérieux is the son of Charles Mérieux (1907–2001), and the grandson of Marcel Mérieux (1870–1937), who founded Institut Mérieux in 1897.
2015
According to Forbes, Mérieux has a net worth of $3.5 billion, as of January 2015.
